MBTPS1 and myocardial ischemia: Bandhuvula et al.[21] demonstrated that cardiac ischemia induced activation of SPL and that inhibition of SPL by either genetic or pharmacologic approaches reduced SPL activity, raised S1P levels, reduced infarct size and increased functional recovery.